155 related articles for article (PubMed ID: 16721008)
41. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.
Aroeira LS; Aguilera A; Sánchez-Tomero JA; Bajo MA; del Peso G; Jiménez-Heffernan JA; Selgas R; López-Cabrera M
J Am Soc Nephrol; 2007 Jul; 18(7):2004-13. PubMed ID: 17568021
[TBL] [Abstract][Full Text] [Related]
42. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
Yokoi H; Kasahara M; Mori K; Ogawa Y; Kuwabara T; Imamaki H; Kawanishi T; Koga K; Ishii A; Kato Y; Mori KP; Toda N; Ohno S; Muramatsu H; Muramatsu T; Sugawara A; Mukoyama M; Nakao K
Kidney Int; 2012 Jan; 81(2):160-9. PubMed ID: 21881556
[TBL] [Abstract][Full Text] [Related]
43. Solute and Water Transport in Peritoneal Dialysis: A Case-Based Primer.
Khanna R
Am J Kidney Dis; 2017 Mar; 69(3):461-472. PubMed ID: 28111028
[TBL] [Abstract][Full Text] [Related]
44. Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.
Schaefer B; Bartosova M; Macher-Goeppinger S; Sallay P; Vörös P; Ranchin B; Vondrak K; Ariceta G; Zaloszyc A; Bayazit AK; Querfeld U; Cerkauskiene R; Testa S; Taylan C; VandeWalle J; Yap Y; Krmar RT; Büscher R; Mühlig AK; Drozdz D; Caliskan S; Lasitschka F; Fathallah-Shaykh S; Verrina E; Klaus G; Arbeiter K; Bhayadia R; Melk A; Romero P; Warady BA; Schaefer F; Ujszaszi A; Schmitt CP
Kidney Int; 2018 Aug; 94(2):419-429. PubMed ID: 29776755
[TBL] [Abstract][Full Text] [Related]
45. Caveolin-1 deficiency induces a MEK-ERK1/2-Snail-1-dependent epithelial-mesenchymal transition and fibrosis during peritoneal dialysis.
Strippoli R; Loureiro J; Moreno V; Benedicto I; Pérez Lozano ML; Barreiro O; Pellinen T; Minguet S; Foronda M; Osteso MT; Calvo E; Vázquez J; López Cabrera M; del Pozo MA
EMBO Mol Med; 2015 Jan; 7(1):102-23. PubMed ID: 25550395
[TBL] [Abstract][Full Text] [Related]
46. Protein kinase C α inhibition prevents peritoneal damage in a mouse model of chronic peritoneal exposure to high-glucose dialysate.
Wang L; Balzer MS; Rong S; Menne J; von Vietinghoff S; Dong L; Gueler F; Jang MS; Xu G; Timrott K; Tkachuk S; Hiss M; Haller H; Shushakova N
Kidney Int; 2016 Jun; 89(6):1253-67. PubMed ID: 27142955
[TBL] [Abstract][Full Text] [Related]
47. Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.
Liappas G; González-Mateo G; Aguirre AR; Abensur H; Albar-Vizcaino P; Parra EG; Sandoval P; Ramírez LG; Del Peso G; Acedo JM; Bajo MA; Selgas R; Sánchez Tomero JA; López-Cabrera M; Aguilera A
Oncotarget; 2016 May; 7(21):30133-46. PubMed ID: 27102153
[TBL] [Abstract][Full Text] [Related]
48. Ultrafiltration Failure Is a Reflection of Peritoneal Alterations in Patients Treated With Peritoneal Dialysis.
Krediet RT
Front Physiol; 2018; 9():1815. PubMed ID: 30618825
[TBL] [Abstract][Full Text] [Related]
49. Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis.
de Lima SM; Otoni A; Sabino Ade P; Dusse LM; Gomes KB; Pinto SW; Marinho MA; Rios DR
Clin Chim Acta; 2013 Jun; 421():46-50. PubMed ID: 23466603
[TBL] [Abstract][Full Text] [Related]
50. Peritoneal morphological and functional changes associated with platelet-derived growth factor B.
Cina D; Patel P; Bethune JC; Thoma J; Rodriguez-Lecompte JC; Hoff CM; Liu L; Margetts PJ
Nephrol Dial Transplant; 2009 Feb; 24(2):448-57. PubMed ID: 18775895
[TBL] [Abstract][Full Text] [Related]
51. Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions.
Liu Y; Li JF; Liu H; Liu FY; Peng YM; Liu YH; Cheng MC; Chen GC; Zhou X
Ren Fail; 2014 Mar; 36(2):292-9. PubMed ID: 24152223
[TBL] [Abstract][Full Text] [Related]
52. Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.
Raby AC; González-Mateo GT; Williams A; Topley N; Fraser D; López-Cabrera M; Labéta MO
Kidney Int; 2018 Aug; 94(2):346-362. PubMed ID: 29861057
[TBL] [Abstract][Full Text] [Related]
53. [Peritoneum as a dialysis membrane. II. Pathology].
Grzybowski A; Breborowicz A
Przegl Lek; 1997; 54(1):52-61. PubMed ID: 9190636
[TBL] [Abstract][Full Text] [Related]
54. Mechanisms of cell death during peritoneal dialysis. A role for osmotic and oxidative stress.
Gotloib L
Contrib Nephrol; 2009; 163():35-44. PubMed ID: 19494593
[TBL] [Abstract][Full Text] [Related]
55. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
56. Peritoneal dialysis: a biological membrane with a nonbiological fluid.
Witowski J; Jörres A
Contrib Nephrol; 2009; 163():27-34. PubMed ID: 19494592
[TBL] [Abstract][Full Text] [Related]
57. Water and solute transport across the peritoneal membrane.
Morelle J; Devuyst O
Curr Opin Nephrol Hypertens; 2015 Sep; 24(5):434-43. PubMed ID: 26197201
[TBL] [Abstract][Full Text] [Related]
58. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
[TBL] [Abstract][Full Text] [Related]
59. Changes in the peritoneal interstitium and their effect on peritoneal transport.
Flessner MF
Perit Dial Int; 1999; 19 Suppl 2():S77-82. PubMed ID: 10406498
[TBL] [Abstract][Full Text] [Related]
60. Determinants of peritoneal membrane function over time.
Davies SJ; Mushahar L; Yu Z; Lambie M
Semin Nephrol; 2011 Mar; 31(2):172-82. PubMed ID: 21439431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
